Search

Marianne P. Allen

Examiner (ID: 17617, Phone: (571)272-0712 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1818, 1812, 1645, 1805, 1631, 1647
Total Applications
2168
Issued Applications
1046
Pending Applications
251
Abandoned Applications
885

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6804937 [patent_doc_number] => 20030232331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Novel proteins and nucleic acids encoding same' [patent_app_type] => new [patent_app_number] => 10/005041 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84936 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232331.pdf [firstpage_image] =>[orig_patent_app_number] => 10005041 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/005041
Novel proteins and nucleic acids encoding same Dec 3, 2001 Abandoned
Array ( [id] => 6157577 [patent_doc_number] => 20020146724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Biopolymer sequence comparison' [patent_app_type] => new [patent_app_number] => 10/006492 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14507 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146724.pdf [firstpage_image] =>[orig_patent_app_number] => 10006492 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/006492
Biopolymer sequence comparison Dec 2, 2001 Issued
Array ( [id] => 5859052 [patent_doc_number] => 20020123104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Human slit polypeptide and polynucleotides encoding same' [patent_app_type] => new [patent_app_number] => 10/011064 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11717 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123104.pdf [firstpage_image] =>[orig_patent_app_number] => 10011064 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/011064
Human slit polypeptide and polynucleotides encoding same Dec 2, 2001 Abandoned
Array ( [id] => 6366501 [patent_doc_number] => 20020059158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Determination of population safe dosage levels of pharmaceutically active substances' [patent_app_type] => new [patent_app_number] => 09/998189 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7292 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20020059158.pdf [firstpage_image] =>[orig_patent_app_number] => 09998189 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/998189
Determination of population safe dosage levels of pharmaceutically active substances Dec 2, 2001 Abandoned
Array ( [id] => 7306895 [patent_doc_number] => 20040116682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Nucleic acid molecules and other molecules associated with the carbon assimilation pathway' [patent_app_type] => new [patent_app_number] => 09/987899 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 152859 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116682.pdf [firstpage_image] =>[orig_patent_app_number] => 09987899 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/987899
Nucleic acid molecules and other molecules associated with the carbon assimilation pathway Nov 15, 2001 Abandoned
Array ( [id] => 6448443 [patent_doc_number] => 20020129004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Software enabled wizards' [patent_app_type] => new [patent_app_number] => 10/039482 [patent_app_country] => US [patent_app_date] => 2001-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 74 [patent_no_of_words] => 19865 [patent_no_of_claims] => 122 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20020129004.pdf [firstpage_image] =>[orig_patent_app_number] => 10039482 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/039482
Software enabled wizards Nov 8, 2001 Abandoned
10/004292 map Oct 28, 2001 Abandoned
Array ( [id] => 6048592 [patent_doc_number] => 20020169108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production' [patent_app_type] => new [patent_app_number] => 10/045534 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 33565 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169108.pdf [firstpage_image] =>[orig_patent_app_number] => 10045534 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/045534
Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production Oct 23, 2001 Abandoned
Array ( [id] => 4979387 [patent_doc_number] => 20070220622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Nucleic acid molecules and other molecules associated with the cytokinin pathway' [patent_app_type] => utility [patent_app_number] => 09/976054 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73558 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20070220622.pdf [firstpage_image] =>[orig_patent_app_number] => 09976054 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/976054
Nucleic acid molecules and other molecules associated with the cytokinin pathway Oct 14, 2001 Issued
Array ( [id] => 6049026 [patent_doc_number] => 20020169297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Genetic insulator for preventing influence by another gene promoter' [patent_app_type] => new [patent_app_number] => 09/973945 [patent_app_country] => US [patent_app_date] => 2001-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10319 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169297.pdf [firstpage_image] =>[orig_patent_app_number] => 09973945 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/973945
Genetic insulator for preventing influence by another gene promoter Oct 10, 2001 Abandoned
Array ( [id] => 949769 [patent_doc_number] => 06963805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-08 [patent_title] => 'Methods for identifying the evolutionarily conserved sequences' [patent_app_type] => utility [patent_app_number] => 09/972595 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20026 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/963/06963805.pdf [firstpage_image] =>[orig_patent_app_number] => 09972595 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/972595
Methods for identifying the evolutionarily conserved sequences Oct 4, 2001 Issued
Array ( [id] => 6080966 [patent_doc_number] => 20020081750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Drug evaluation operating principles' [patent_app_type] => new [patent_app_number] => 09/956094 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8412 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081750.pdf [firstpage_image] =>[orig_patent_app_number] => 09956094 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/956094
Drug evaluation operating principles Sep 19, 2001 Abandoned
Array ( [id] => 6157682 [patent_doc_number] => 20020146751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'fabF' [patent_app_type] => new [patent_app_number] => 09/956398 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16101 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146751.pdf [firstpage_image] =>[orig_patent_app_number] => 09956398 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/956398
fabF Sep 18, 2001 Abandoned
Array ( [id] => 6756542 [patent_doc_number] => 20030004319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Mammalian growth factor' [patent_app_type] => new [patent_app_number] => 09/940601 [patent_app_country] => US [patent_app_date] => 2001-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10085 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004319.pdf [firstpage_image] =>[orig_patent_app_number] => 09940601 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/940601
Mammalian growth factor Aug 26, 2001 Abandoned
Array ( [id] => 6157716 [patent_doc_number] => 20020146764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Expression using fused genes providing for protein product' [patent_app_type] => new [patent_app_number] => 09/931216 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9841 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146764.pdf [firstpage_image] =>[orig_patent_app_number] => 09931216 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/931216
Expression using fused genes providing for protein product Aug 15, 2001 Abandoned
Array ( [id] => 5921743 [patent_doc_number] => 20020115144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Compositions for the diagnosis and treatment of chediak-higashi syndrome' [patent_app_type] => new [patent_app_number] => 09/927668 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 91 [patent_no_of_words] => 24295 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115144.pdf [firstpage_image] =>[orig_patent_app_number] => 09927668 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/927668
Compositions for the diagnosis and treatment of chediak-higashi syndrome Aug 9, 2001 Abandoned
Array ( [id] => 7394039 [patent_doc_number] => 20040038341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Chimeric human-type vascular endothelial cell growth factor' [patent_app_type] => new [patent_app_number] => 10/343825 [patent_app_country] => US [patent_app_date] => 2003-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9274 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038341.pdf [firstpage_image] =>[orig_patent_app_number] => 10343825 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/343825
Chimeric human-type vascular endothelial cell growth factor Aug 8, 2001 Issued
09/890689 Cdna sequence of an iteractor fancip1 of the fanconi anaemia protein of complementation group a Aug 1, 2001 Abandoned
Array ( [id] => 6869855 [patent_doc_number] => 20030082544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Methods and systems for validating detection assays, developing in-vitro diagnostic DNA or RNA analysis products, and increasing revenue and/or profit margins from in-vitro diagnostic DNA or RNA analysis assays' [patent_app_type] => new [patent_app_number] => 09/915063 [patent_app_country] => US [patent_app_date] => 2001-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 44688 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082544.pdf [firstpage_image] =>[orig_patent_app_number] => 09915063 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/915063
Methods and systems for validating detection assays, developing in-vitro diagnostic DNA or RNA analysis products, and increasing revenue and/or profit margins from in-vitro diagnostic DNA or RNA analysis assays Jul 24, 2001 Abandoned
Array ( [id] => 1137576 [patent_doc_number] => 06780600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-24 [patent_title] => 'Synaptic activation protein compositions and method' [patent_app_type] => B2 [patent_app_number] => 09/910706 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 35 [patent_no_of_words] => 12339 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780600.pdf [firstpage_image] =>[orig_patent_app_number] => 09910706 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/910706
Synaptic activation protein compositions and method Jul 19, 2001 Issued
Menu